TRAF6 Antikörper

Produktnummer ABIN537432

Produktdetails anti-TRAF6 Antikörper

Target: TRAF6 (TNF Receptor-Associated Factor 6 (TRAF6))

Reaktivität: Rind (Kuh)

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser TRAF6 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Verwendungszweck: Rabbit polyclonal antibody raised against synthetic peptide of TRAF6.

Sequenz: DAKPELLAFQ RPTIPRNPK

Kreuzreaktivität: Human, Maus, Ratte

Immunogen: A synthetic peptide corresponding to amino acids 451-469 of human TRAF6.

Anwendungsinformationen

Applikationshinweise: The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In serum (0.05 % sodium azide)

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-TRAF6 Antikörper (ABIN537432)

Ichii, Otsuka, Sasaki, Namiki, Hashimoto, Kon: "Altered expression of microRNA miR-146a correlates with the development of chronic renal inflammation." in: Kidney international, Vol. 81, Issue 3, pp. 280-92, (2012) (PubMed).

Zucchelli, Codrich, Marcuzzi, Pinto, Vilotti, Biagioli, Ferrer, Gustincich: "TRAF6 promotes atypical ubiquitination of mutant DJ-1 and alpha-synuclein and is localized to Lewy bodies in sporadic Parkinson's disease brains." in: Human molecular genetics, Vol. 19, Issue 19, pp. 3759-70, (2010) (PubMed).

Zapata, Krajewska, Krajewski, Kitada, Welsh, Monks, McCloskey, Gordon, Kipps, Gascoyne, Shabaik, Reed: "TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 165, Issue 9, pp. 5084-96, (2000) (PubMed).

Details zu TRAF6

Target: TRAF6 (TNF Receptor-Associated Factor 6 (TRAF6))

Andere Bezeichnung: TRAF6 / RNF85 (TRAF6 Produkte)

Synonyme: MGC:3310 antikoerper, RNF85 antikoerper, 2310003F17Rik antikoerper, AI851288 antikoerper, C630032O20Rik antikoerper, rnf85 antikoerper, traf6 antikoerper, xtraf6 antikoerper, CG10961 antikoerper, DTRAF2 antikoerper, Dmel\\CG10961 antikoerper, TRAF antikoerper, TRAF2 antikoerper, TRAF6 antikoerper, Traf2 antikoerper, dTRAF2 antikoerper, dTRAF6 antikoerper, dTraf2 antikoerper, dtraf2 antikoerper, GB10539 antikoerper, fi15f02 antikoerper, wu:fi15f02 antikoerper, zgc:63704 antikoerper, TNF receptor associated factor 6 antikoerper, TNF receptor-associated factor 6 antikoerper, TNF receptor associated factor 6 L homeolog antikoerper, TNF-receptor-associated factor 6 antikoerper, TNF receptor associated factor 6 S homeolog antikoerper, TRAF6 antikoerper, Traf6 antikoerper, traf6.L antikoerper, traf6 antikoerper, LOC551819 antikoerper, traf6.S antikoerper

Pathways: NF-kappaB Signalweg, T-Zell Rezeptor Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Neurotrophin Signalübertragung, Activation of Innate immune Response, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Tube Formation, Hepatitis C, Toll-Like Receptors Cascades, Ubiquitin Proteasome Pathway